Publications by authors named "N Roma"
Background: Compared to older adults with breast cancer (BC), adolescents and young adults (AYAs) develop more aggressive disease necessitating more intensive therapy with curative intent, which is disruptive to planned life trajectories. The burden of unmet needs among AYA BC survivors exists in two domains: (1) symptoms (e.g.
View Article and Find Full Text PDFObjectives: To study the national trends of anticoagulants, antiarrhythmic drugs (AADs), and expenditures in the civilian noninstitutionalized atrial fibrillation (AF) population.
Methods: The Medical Expenditure Panel Survey was queried from January 2016 to December 2021 to identify adults (age ≥18 years) with a diagnosis of AF utilizing the International Classification of Diseases, Tenth Revision, Clinical Modification code I48. Prevalence of anticoagulants (AAD) and its expenditure and AF expenditure across clinical settings in the United States were estimated.
Article Synopsis
- Aspirin (ASA) has been the leading antiplatelet medication since 1897 for preventing and treating cardiovascular diseases, prompting a study on its trends and costs in the USA from 2000 to 2021.
- The research found that ASA users increased from 2.9 million to 6.6 million, with a notable rise in usage among women and African Americans, while low-dose use gained popularity and high-dose use decreased.
- Approximately 60 million USD was spent annually on ASA, with half of its users having no known cardiovascular disease, especially among individuals aged 50-69 and those over 70, indicating a need for further research on the implications of this increasing usage.
Article Synopsis
- * Analysis showed a decline in AMI hospitalizations and revascularization procedures, along with an increase in in-hospital mortality rates in 2020 compared to 2019.
- * The findings suggest that the pandemic significantly affected AMI outcomes, indicating a need for further research to understand the factors leading to higher mortality rates during such crises.
Background: Cardiac arrest (CA) affects over 600,000 patients in the USA annually. Despite large-scale public health and educational initiatives, survival rates are lower in certain racial and socioeconomic groups.
Methods: A county-level cross-sectional longitudinal study using death data of patients aged 15 years or more from the US Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (WONDER) database from 1999 to 2020.